In-Vitro Cancer Diagnostics Market – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Request Brochure Request Discount

Report Code: ZMR-130 | Report Format : | Status : Upcoming |

Abstract

Cancer is an uncontrolled growth of cell. Uncontrolled growth of cell leads to formation of tumor which can interfere with the digestive, nervous, and circulatory systems. Tumor cell releases hormones that alter body functions. Tumors that stay in one location and show limited growth are considered as benign cancer. Whereas, the cancerous cell which flow throughout the body part, using lymph, blood, and destroying the healthy tissue are called malignant cancer. According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012.

There are over 200 different types of cancer, and each of which is classified by the type of cell that is initially affected. Various types of cancer include, prostrate cancer, blood cancer, lungs cancer etc. Cancer is diagnosed with the help of various in-vitro cancer test which include immunoassay, immunohistochemistry, clinical chemistry and nucleic acid tests (NAT). The global in vitro diagnostics (IVD) market size was estimated at USD 51,674.4 million in 2013.

Major factors responsible for the growth of in-vitro cancer diagnostics market are the rising incidences of chronic lifestyle diseases across the globe. Furthermore, growing aging population, and increasing usage of point-of-care testing and personalized medicine are also fueling the growth of in-vitro diagnostics market. Moreover, a new range of condition-specific markers and tests with advances in genomics and proteomics and increasing investment in emerging countries are creating new opportunities for this market. However, inadequate returning policy and stringent regulatory approval framework are restraining the growth of this market. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies is expected to open growth avenues for the market over the years.

The report covers forecast and analysis of the in-vitro cancer diagnostics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million).  To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the in-vitro cancer diagnostics market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides detailed segmentation of the in-vitro cancer diagnostics market based on products, technology, application and regional segment. The technology market segment held the largest market share in 2015.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America was the leading segment of in-vitro cancer diagnostic market with 43% market share in 2014. Due to the presence of advanced technologies, superlative opportunities for molecular diagnostics in genetic testing, cancer screening, and the presence of a large number of leading market players such as Abbott Laboratories, Inc., Johnson and Johnson etc. followed by Europe. The in-vitro cancer diagnostics market is expected to witness the growth in the Asia-Pacific region in the coming years due to advance diagnostics rising in population, healthcare infrastructure, and growing per capita healthcare expenditure.

According to the report, the chief market players for in-vitro cancer diagnostic market are Roche Diagnostics, Abbott Laboratories, Inc., Becton, Dickson and Company, Ortho-Clinical Diagnostics, Johnson and Johnson, Danaher Corporation, Thermo Fisher Scientific, Inc, Siemens Healthcare, Bio-Rad Laboratories, Inc., Sysmex Corporation, and bioMérieux.

This report segments in-vitro cancer diagnostics market as follows:

In-vitro Cancer Diagnostic Market: Product Segment Analysis

  • Instruments
  • Reagents and Kits
  • Data Management System/Software
  • Services

In-vitro Cancer Diagnostic Market: Technology Segment Analysis

  • Clinical Chemistry
  • Immunochemistry/Immunoassays
  • Hematology
  • Coagulation and Hemostasis
  • Microbiology
  • Molecular Diagnostics
  • Other IVD Technologies

In-vitro Cancer Diagnostic Market: Application Segment Analysis

  • Laboratories
  • Hospitals
  • Academic Institutes
  • Point-of-care Testing
  • Patient Self-testing
  • Other End Users

In-vitro Cancer Diagnostic Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East & Africa

Related Reports

Fundus Cameras Market: by Product Type (Mydriatic Fundus Cameras [Tabletop and Handheld], Non-mydriatic Fundus Cameras [Tabletop and Handheld], Hybrid Fundus Cameras, and ROP Fundus Cameras) and by End User (Hospitals, Ophthalmology Clinics, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 120 | Report Code: ZMR-3275 | Report Format:

The report covers forecast and analysis for the fundus cameras market on a global and regional level. The study provides historic data upto 2017 along with the forecast from 2018 to 2024 based on revenue (USD Million).The study includes drivers and restraints for the fundus cameras market along wi...Read More

CT Scanner Market: by Product Type (C-Arm CT Scanners and O-Arm CT Scanners), by Modality (Standalone CT Scanners and Portable CT Scanners), by Technology (High-Slice CT, Mid-Slice CT, Low-Slice CT, and Cone Beam CT (CBCT)) and by End-users (Hospitals, Diagnostic Centers, Research & Academic Institution, Ambulatory Care Centers, Veterinary Clinics and Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3274 | Report Format:

The report covers forecast and analysis for the CT scanner market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based revenue (USD Million). The study includes drivers and restraints for the CT scanner market along with t...Read More

Surgical Equipment Market by Product (Surgical Sutures and Stapler, Handheld Surgical Devices, and Electrosurgical Devices), by Application (Neurosurgery, Plastic and Reconstructive Surgery, Wound Closure, Obstetrics and Gynecology, Cardiovascular, Orthopedic, and Others), and by Category (Reusable Surgical Equipments and Disposable Surgical Equipments): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Aug-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3273 | Report Format:

The report covers forecast and analysis for the surgical equipment market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the surgical equipmen...Read More

Surgical Stapling Devices Market by Product Type (Powered Surgical Stapling Device and Manual Surgical Stapling Device), By Usage (Disposable Surgical Stapling Device and Reusable Surgical Stapling), By Type of Stapling (Straight Stapling, Curved Stapling, and Circular Stapling), By Surgical Indication (Skin, Digestive Tract, Blood Vessels, Hernia, Lung and others), and By End-User (Hospitals, Ambulatory Surgical Centers and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Jul-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3246 | Report Format:

The report covers forecast and analysis for the surgical stapling devices market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based revenue (USD Billion). The study includes drivers and restraints for the surgical...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.